Vivanza Biosciences Share Price
Know More₹2.08-0.01 (-0.48%)
04:00 PM, 24-Dec-2025BSE : 530057
Sector : Health care
ISIN Code : INE984E01035
- BSE
- 1D
- 5D
- 1M
- 6M
- 1Y
- 2Y
- 5Y
- MAX
Last Updated: 24-Dec-2025 | 04:00 PM IST
| Market Cap (₹ Cr) | 8 |
Traded Value (₹ Cr) | 0.02 |
Volume (Shares) | 81,610 |
Face Value (₹) | 1 |
52-Week High (₹) | 3.95 |
52-Week High Date | 09-Jan-2025 |
52-Week Low (₹) | 1.90 |
52-Week Low Date | 01-Apr-2025 |
All Time High (₹) | 21.00 |
All Time High Date | 01-Nov-2021 |
All Time Low (₹) | 0.05 |
All Time Low Date | 27-May-1997 |
Vivanza Biosciences Ltd
Market News
Vivanza Biosci. Announcement
Vivanza Biosciences Ltd - Key Fundamentals
| PARAMETER | VALUES |
|---|---|
| Market Cap (₹ Cr) | 8 |
| EPS - TTM (₹) [C] | -0.08 |
| P/E Ratio (X) [C] | -26.00 |
| Face Value (₹) | 1 |
| Latest Dividend (%) | - |
| Latest Dividend Date | - |
| Dividend Yield (%) | - |
| Book Value Share (₹) [C] | 1.15 |
| P/B Ratio (₹) [C] | 1.81 |
Funds Owning this Stock
| Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
|---|---|---|---|
| Data Not Found | |||
Research Reports
| Date | Broker | Action | Prices(₹) | Report |
|---|---|---|---|---|
| Data Not Found | ||||
Stock Strength
| Today's Low/High (₹) | 2.00 2.18 |
| Week Low/High (₹) | 2.00 2.18 |
| Month Low/High (₹) | 2.00 2.00 |
| Year Low/High (₹) | 1.90 4.00 |
| All time Low/High (₹) | 0.05 21.00 |
Share Price Returns
| Period | BSE | NSE | SENSEX | NIFTY |
|---|---|---|---|---|
| 1 Week | 2.46% | - | 1.00% | 1.25% |
| 1 Month | -11.49% | - | 0.60% | 0.70% |
| 3 Month | 0.97% | - | 4.52% | 4.33% |
| 6 Month | -4.15% | - | 4.09% | 4.38% |
| 1 Year | -35.80% | - | 8.84% | 10.18% |
| 3 Year | -86.67% | - | 42.72% | 46.81% |
Company Info
Company Information
Executive Director & MD : Jayendra Mehta
Non Executive Director : Hemant Amrish Parikh
Independent Non Exe. Director : Rina Kumari
Independent Non Exe. Director : Hitesh Pradeep Rijwani
Non-Exec & Non-Independent Dir : SARANG PATHAK
Company Sec. & Compli. Officer : Chaitra Arora
Registered Office: 403 Sarthik 2 Opp Rajpath Club, S G Highway,Ahmedabad,Gujarat-380054 Ph: 91-07405699869
FAQs about Vivanza Biosciences Ltd
1. What's the Vivanza Biosciences Ltd share price today?
Vivanza Biosciences Ltd share price was Rs 2.08 at 04:00 PM IST on 24th Dec 2025. Vivanza Biosciences Ltd share price was down by 0.48% from the previous closing price of Rs 2.09. Vivanza Biosciences Ltd share price trend:
- Last 1 Month: Vivanza Biosciences Ltd share price moved down by 11.49% on BSE.
- Last 3 Months: Vivanza Biosciences Ltd share price moved up by 0.97% on BSE.
- Last 12 Months: Vivanza Biosciences Ltd share price moved down by 35.80% on BSE.
- Last 3 Years: Vivanza Biosciences Ltd share price moved down by 86.67% on BSE.
2. How can I quickly analyse the performance of the Vivanza Biosciences Ltd stock?
The performance of the Vivanza Biosciences Ltd stock can be quickly analysed on the following metrics:
- The stock's PE is -26.00
- Price to book value ratio is 1.81
- The EPS (trailing 12 months) of the Vivanza Biosciences Ltd stock is Rs -0.08
3. What is the market cap of Vivanza Biosciences Ltd?
Vivanza Biosciences Ltd has a market capitalisation of Rs 8 crore.
4. What is Vivanza Biosciences Ltd's 52-week high/low share price?
The Vivanza Biosciences Ltd’s 52-week high share price is Rs 3.95 and 52-week low share price is Rs 1.90.
5. Is the Vivanza Biosciences Ltd profitable?
On a consolidated basis, Vivanza Biosciences Ltd reported a profit of Rs 0.56 crore on a total income of Rs 55.37 crore for the quarter ended 2025.
6. Which are Vivanza Biosciences Ltd’s peers in the Health care sector?
Vivanza Biosciences Ltd’s top 5 peers in the Health care sector are Parmax Pharma, Unjha Formul., Decipher Labs, Vivanza Biosci., Kobo Biotech, Hind.Bio Science, Fabino Enter.
7. Who owns how much in Vivanza Biosciences Ltd?
Key changes to the Vivanza Biosciences Ltd shareholding are as follows:
- Promoter holding in Vivanza Biosciences Ltd has gone up to 20.02 per cent as of Sep 2025 from 20.02 per cent as of Dec 2024.
